DUAL GLP-1/GIP RECEPTOR AGONISTS

摘要

The present invention relates to exendin-4 derivatives and their medical use, for example in the treatment of disorders of the metabolic syndrome, including diabetes and obesity, as well as reduction of excess food intake.